A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Weight-based dosing of surgical antibiotic prophylaxis in patients with obesity: meta-analysis




TekijätHuisman, Hiske; Huinink, Karlijn; Bontekoning, Nathan; de Jonge, Stijn W.; Hannink, Gerjon; Salminen, Paulina; Boermeester, Marja A.

KustantajaOxford University Press (OUP)

Julkaisuvuosi2026

Lehti: BJS Open

Artikkelin numerozrag015

Vuosikerta10

Numero2

eISSN2474-9842

DOIhttps://doi.org/10.1093/bjsopen/zrag015

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Kokonaan avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1093/bjsopen/zrag015

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/523274116

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä

Background

The use of preoperative surgical antibiotic prophylaxis is effective in preventing surgical site infection. However, obesity, a major risk factor for surgical site infection, affects the pharmacokinetics and effectiveness of surgical antibiotic prophylaxis. Evidence for weight-based surgical antibiotic prophylaxis in patients with obesity is inconsistent.

Methods

MEDLINE (PubMed), Embase, CENTRAL, and CINAHL were searched up to 21 October 2025 for eligible studies on weight-based surgical antibiotic prophylaxis and surgical site infection. This systematic review and random-effects meta-analysis compared weight-based dosing of surgical antibiotic prophylaxis with standard surgical antibiotic prophylaxis, in terms of surgical site infection rates in patients with obesity. The certainty of evidence was evaluated using the Revised Cochrane risk-of-bias tool for randomized trials, the Risk Of Bias in Non-randomized Studies—of Interventions tool for observational studies, and Grading of Recommendations Assessment, Development and Evaluation (GRADE).

Results

Of 2782 potentially relevant articles, 33 studies were eligible (3 randomized clinical trials, 30 observational). A total of 99 211 patients were included, of whom 2362 (2.4%) developed a surgical site infection. Risk of bias varied from ‘low’ to ‘some concerns’ in randomized trials, and ‘some concerns’ to ‘serious’ in observational studies. Meta-analysis of 3 randomized trials with only 1 surgical site infection among 103 patients (1.0%) showed no significant reduction in surgical site infection rates in patients receiving weight-based dosing of cefazolin versus standard dosing (risk difference 2.02 (95% confidence interval −3.15 to 7.19)%). Meta-analysis of 6 observational studies with 45 554 patients and 610 surgical site infections (1.3%) showed significantly reduced surgical site infection rates in patients receiving weight-based dosing of cefazolin versus standard dosing (risk difference −1.93 (−2.84 to −1.02)%), with most studies focusing on orthopaedic surgery. GRADE assessments showed very low certainty of evidence.

Conclusion

Based on observational data, the use of weight-based dosing of surgical antibiotic prophylaxis may reduce the risk of surgical site infection in patients with obesity compared with standard dosing, but the existing evidence is very uncertain.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
This authors have no funding to declare.


Last updated on